• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺移植后需要早期再次剖腹手术的外科并发症:环孢素时代的多变量危险因素及经济影响分析

Surgical complications requiring early relaparotomy after pancreas transplantation: a multivariate risk factor and economic impact analysis of the cyclosporine era.

作者信息

Troppmann C, Gruessner A C, Dunn D L, Sutherland D E, Gruessner R W

机构信息

Department of Surgery, University of Minnesota, Minneapolis 55455, USA.

出版信息

Ann Surg. 1998 Feb;227(2):255-68. doi: 10.1097/00000658-199802000-00016.

DOI:10.1097/00000658-199802000-00016
PMID:9488525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1191244/
Abstract

OBJECTIVES

To study significant surgical complications requiring early (< or = 3 months posttransplant) relaparotomy (relap) after pancreas transplants, and to develop clinically relevant surgical and peritransplant decision-making guidelines for preventing and managing such complications.

SUMMARY BACKGROUND DATA

Pancreas grafts are still associated with the highest surgical complication rate of all routinely transplanted solid organs. However, the impact of surgical complications on morbidity, hospital costs, and graft and patient survival rates has not been analyzed in detail to date.

METHODS

We retrospectively studied surgical complications requiring relap in 441 consecutive cadaver, bladder-drained pancreas transplants (54% simultaneous pancreas and kidney [SPK]; 22% pancreas after kidney [PAK]; 24% pancreas transplant alone [PTA]; 37% retransplant). Outcome and hospital charges were analyzed separately for recipients with versus without reoperation.

RESULTS

The overall relap rate was 32% (SPK, 36%; PAK, 25%; PTA, 16%; p = 0.04). The most common causes were intraabdominal infection and graft pancreatitis (38%), pancreas graft thrombosis (27%), and anastomotic leak (15%). Perioperative relap mortality was 9%; transplant pancreatectomy was necessary in 57% of all recipients with one or more relaps. The pancreas graft was lost in 80% of recipients with versus 41% without relap (p < 0.0001). Patient survival rates were significantly lower (p < 0.05) for recipients with versus without relap. By multivariate analysis, significant risk factors for graft loss included older donor age (SPK, PAK), retransplant (PAK), relap for infection (SPK, PAK), and relap for leak or bleeding (PAK). For death, risk factors included older recipient age (SPK, PAK),retransplant (SPK, PAK), relap for thrombosis (PAK), relap for infection or leak (SPK), and relap for bleeding (PTA).

CONCLUSIONS

Posttransplant surgical complications requiring relap were frequent, resulted in a high rate of pancreas (SPK, PAK, PTA) and kidney (SPK, PAK) graft loss, and had a major economic impact (p = 0.0001). Complications were associated with substantial perioperative mortality and decreased patient survival rates. The focus must therefore shift from graft salvage to preservation of the recipient's life once a pancreas graft-related complication requiring relap occurs. Thus, the threshold for pancreatectomy should be low. In this context, acceptance of older donors and recipients must be reconsidered.

摘要

目的

研究胰腺移植后需要早期(移植后≤3个月)再次剖腹手术(再次手术)的严重手术并发症,并制定具有临床相关性的手术及移植围手术期决策指南,以预防和处理此类并发症。

总结背景资料

胰腺移植物仍是所有常规移植实体器官中手术并发症发生率最高的。然而,迄今为止,手术并发症对发病率、医院费用以及移植物和患者生存率的影响尚未得到详细分析。

方法

我们回顾性研究了441例连续的尸体供体膀胱引流式胰腺移植中需要再次手术的手术并发症(54%为胰肾联合移植[SPK];22%为肾移植后胰腺移植[PAK];24%为单纯胰腺移植[PTA];37%为再次移植)。分别分析了再次手术和未再次手术受者的结局及住院费用。

结果

总体再次手术率为32%(SPK为36%;PAK为25%;PTA为16%;p = 0.04)。最常见的原因是腹腔内感染和移植胰腺胰腺炎(38%)、胰腺移植物血栓形成(27%)以及吻合口漏(15%)。围手术期再次手术死亡率为9%;在所有有一次或多次再次手术的受者中,57%需要进行移植胰腺切除术。有再次手术的受者中80%的胰腺移植物丢失,而未再次手术的受者中这一比例为41%(p < 0.0001)。有再次手术的受者的患者生存率显著低于未再次手术的受者(p < 0.05)。多因素分析显示,移植物丢失的显著危险因素包括供体年龄较大(SPK、PAK)、再次移植(PAK)、因感染进行再次手术(SPK、PAK)以及因漏血进行再次手术(PAK)。对于死亡,危险因素包括受者年龄较大(SPK)、再次移植(SPK、PAK)、因血栓形成进行再次手术(PAK)、因感染或漏进行再次手术(SPK)以及因出血进行再次手术(PTA)。

结论

移植后需要再次手术的手术并发症很常见,导致胰腺(SPK、PAK、PTA)和肾脏(SPK、PAK)移植物丢失率很高,并产生重大经济影响(p = 0.0001)。并发症与围手术期高死亡率及患者生存率降低相关。因此,一旦发生需要再次手术的胰腺移植物相关并发症,重点必须从挽救移植物转向挽救受者生命。所以,胰腺切除术的阈值应较低。在此背景下,必须重新考虑对老年供体和受者的接受问题。

相似文献

1
Surgical complications requiring early relaparotomy after pancreas transplantation: a multivariate risk factor and economic impact analysis of the cyclosporine era.胰腺移植后需要早期再次剖腹手术的外科并发症:环孢素时代的多变量危险因素及经济影响分析
Ann Surg. 1998 Feb;227(2):255-68. doi: 10.1097/00000658-199802000-00016.
2
The surgical risk of pancreas transplantation in the cyclosporine era: an overview.环孢素时代胰腺移植的手术风险:综述
J Am Coll Surg. 1997 Aug;185(2):128-44. doi: 10.1016/s1072-7515(01)00895-x.
3
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.FK506用于胰腺移植后诱导和挽救治疗的首次经验的多中心分析。
Transplantation. 1996 Jan 27;61(2):261-73. doi: 10.1097/00007890-199601270-00018.
4
Lessons learned from more than 1,000 pancreas transplants at a single institution.从一家机构进行的1000多例胰腺移植中吸取的经验教训。
Ann Surg. 2001 Apr;233(4):463-501. doi: 10.1097/00000658-200104000-00003.
5
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002.截至2002年10月,向器官共享联合网络(UNOS)和国际胰腺移植登记处(IPTR)报告的美国及非美国病例的胰腺移植结果。
Clin Transpl. 2002:41-77.
6
Pancreas after kidney transplants.肾移植后的胰腺
Am J Surg. 2001 Aug;182(2):155-61. doi: 10.1016/s0002-9610(01)00676-6.
7
Analysis of United States (US) and non-US pancreas transplants reported to the United network for organ sharing (UNOS) and the international pancreas transplant registry (IPTR) as of October 2001.截至2001年10月,对向美国器官共享联合网络(UNOS)和国际胰腺移植登记处(IPTR)报告的美国及非美国胰腺移植情况进行分析。
Clin Transpl. 2001:41-72.
8
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004.截至2004年6月,向器官共享联合网络(UNOS)和国际胰腺移植登记处(IPTR)报告的美国及非美国病例的胰腺移植结果。
Clin Transplant. 2005 Aug;19(4):433-55. doi: 10.1111/j.1399-0012.2005.00378.x.
9
Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000.截至2000年10月,向器官共享联合网络(UNOS)报告的美国胰腺移植病例以及向国际胰腺移植登记处(IPTR)报告的非美国胰腺移植病例的结果。
Clin Transpl. 2000:45-72.
10
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003.截至2003年5月,向器官共享联合网络(UNOS)和国际胰腺移植登记处(IPTR)报告的美国及非美国病例的胰腺移植结果。
Clin Transpl. 2003:21-51.

引用本文的文献

1
Kidney Delayed Graft Function in Simultaneous Pancreas-Kidney Transplant Recipients Is Associated With Inferior Outcomes.胰肾联合移植受者的肾脏延迟移植功能与较差的预后相关。
Transplant Direct. 2025 Apr 17;11(5):e1797. doi: 10.1097/TXD.0000000000001797. eCollection 2025 May.
2
Dueling with the dual artery blood supply in pancreas transplantation: why replace the Y?胰腺移植中双动脉血供的权衡:为何要替换“Y”形结构?
Gland Surg. 2024 Jul 30;13(7):1159-1163. doi: 10.21037/gs-24-121. Epub 2024 Jul 17.
3
Nutritional Risk of Candidates for Simultaneous Pancreatic-Kidney Transplantation-A Narrative Review.同时接受胰肾移植候选人的营养风险:一篇叙述性综述。
Nutrients. 2023 Sep 27;15(19):4179. doi: 10.3390/nu15194179.
4
Improved surgical outcomes following simultaneous pancreas-kidney transplantation in the contemporary era.在当代,胰肾联合移植术后的手术效果得到了改善。
Clin Transplant. 2022 Nov;36(11):e14792. doi: 10.1111/ctr.14792. Epub 2022 Sep 8.
5
Comparison of color Doppler ultrasonography and computed tomography angiography (CTA) and computed tomography venography (CTV) in the diagnosis of arteriovenous thrombosis after simultaneous pancreas-kidney transplantation: a retrospective diagnostic accuracy study.彩色多普勒超声检查与计算机断层血管造影(CTA)及计算机断层静脉造影(CTV)在同期胰肾联合移植术后动静脉血栓形成诊断中的比较:一项回顾性诊断准确性研究
Ann Transl Med. 2022 Jul;10(14):770. doi: 10.21037/atm-22-3134.
6
Extracellular Vesicles in Type 1 Diabetes: A Versatile Tool.1型糖尿病中的细胞外囊泡:一种多功能工具。
Bioengineering (Basel). 2022 Mar 4;9(3):105. doi: 10.3390/bioengineering9030105.
7
Simultaneous pancreas-kidney transplantation: Early complications and long-term outcomes - a single-center experience.胰肾联合移植:早期并发症及长期预后——单中心经验
Can Urol Assoc J. 2022 Jul;16(7):E357-E362. doi: 10.5489/cuaj.7635.
8
Challenges Associated with Pancreas and Kidney Retransplantation-A Retrospective Analysis.胰腺和肾脏再次移植相关挑战——一项回顾性分析
J Clin Med. 2021 Aug 17;10(16):3634. doi: 10.3390/jcm10163634.
9
Interventions for preventing thrombosis in solid organ transplant recipients.实体器官移植受者的血栓预防干预措施。
Cochrane Database Syst Rev. 2021 Mar 15;3(3):CD011557. doi: 10.1002/14651858.CD011557.pub2.
10
Recipient age and outcome after pancreas transplantation: a retrospective dual-center analysis.受体年龄与胰腺移植术后结局:一项回顾性的双中心分析。
Transpl Int. 2021 Apr;34(4):657-668. doi: 10.1111/tri.13845. Epub 2021 Mar 1.

本文引用的文献

1
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.他克莫司在胰腺移植中的应用:一项多中心分析。他克莫司胰腺移植研究组。
Clin Transplant. 1997 Aug;11(4):299-312.
2
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.胰腺移植术后腹腔内真菌感染:发病率、治疗及预后
J Am Coll Surg. 1996 Oct;183(4):307-16.
3
Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome.胰肾联合移植后内分泌胰腺移植功能延迟。发生率、危险因素及其对长期预后的影响。
Transplantation. 1996 May 15;61(9):1323-30. doi: 10.1097/00007890-199605150-00007.
4
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis.胰腺移植术后血管移植物血栓形成:单因素和多因素手术及非手术风险因素分析
J Am Coll Surg. 1996 Apr;182(4):285-316.
5
Positive duodenal segment cultures are not associated with increased surgical complications after whole organ, bladder-drained pancreas transplantation in three recipient categories.在三类受者中,全器官、膀胱引流式胰腺移植术后十二指肠段培养结果呈阳性与手术并发症增加无关。
Transplant Proc. 1995 Dec;27(6):3101-3.
6
Octreotide.奥曲肽
N Engl J Med. 1996 Jan 25;334(4):246-54. doi: 10.1056/NEJM199601253340408.
7
Cystoenteric conversion after whole pancreaticoduodenal transplantation: indications, risk factors, and outcome.全胰十二指肠移植术后的膀胱肠道改道:适应症、危险因素及结果
Transplant Proc. 1993 Feb;25(1 Pt 2):1179-81.
8
A comparative analysis of results and morbidity in type I diabetics undergoing preemptive versus postdialysis combined pancreas-kidney transplantation.对接受预先移植与透析后联合胰腺-肾脏移植的I型糖尿病患者的结果和发病率进行比较分析。
Transplantation. 1993 May;55(5):1097-103. doi: 10.1097/00007890-199305000-00031.
9
Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup.筛查糖尿病移植候选者的冠状动脉疾病:识别低风险亚组。
Kidney Int. 1993 Sep;44(3):617-21. doi: 10.1038/ki.1993.289.
10
Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients.胰腺移植受者植入后胰腺炎和胰腺血栓形成的危险因素。
Transplantation. 1993 Sep;56(3):609-12. doi: 10.1097/00007890-199309000-00021.